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Abstract To investigate the molecular chaperone function of
trigger factor (TF) and its relationship with isomerase activity in
vivo, the assisted folding of adenylate kinase (AK) by TF in
Escherichia coli was examined by measuring the amounts of
soluble AK produced during co-expression. When the mutant of
chicken AK, P17G, is expressed in plasmid pBVAK, 95% of the
protein is found in inclusion bodies. Co-expression of AK with TF
was achieved using a plasmid pBVAT that allowed expression of
TF and AK in the same plasmid under separate control. Co-
expression with TF resulted in an increase in the amount of
soluble AK, with a higher increase when TF was expressed at
higher levels in the cell. Co-expression of AK with the two TF
mutants, Y221G and F233Y, in which peptidyl-prolyl cis/trans
isomerase activity was 1% of wild-type, gave the same results as
wild-type TF. This provides in vivo evidence that the molecular
chaperone activity of TF is distinct from its isomerase
activity. ß 2001 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
The Escherichia coli trigger factor (TF) was originally iden-
ti¢ed as being involved in the maintenance of a translocation-
competent conformation of the precursor protein proOmpA
(outer membrane protein A) in a cell-free translation system
[1,2], although subsequent research failed to verify this [3].
Later it was identi¢ed as a peptidyl-prolyl cis/trans isomerase
(PPIase) [4,5] and was detected in the 50S subunit of the func-
tional ribosome, which covers the exit domain of the nascent
polypeptide chain [5,6]. In further studies, presecretory and
non-secretory proteins have been crosslinked to TF while still
associated with the ribosome [5,7]. Further, TF is active in
cooperating with chaperones such as GroEL and DnaK and is
itself an important chaperone in nascent peptide folding [7^
12]. We found in previous in vitro studies on guanidine dena-
tured GAPDH that an excess of TF assists reactivation and
prevents aggregation, by repeated binding and release cycles
between TF and folding intermediates during refolding [13].
TF recognizes random coil or loosely formed secondary struc-
tures, suggesting that TF interacts with the nascent chain and
is involved in the earliest stages of peptide folding [14]. A
recent study showed that co-expression of TF in combination
with GroEL/GroES is helpful in preventing aggregation of a
number of recombinant proteins [15]. These results suggest
that TF might be useful in preventing aggregation of recombi-
nant proteins in E. coli and thus improve the yield of soluble
protein.
TF is a protein that shows both molecular chaperone and
PPIase activities. In order to understand the relationship be-
tween the chaperone activity and PPIase activity, we used two
TF mutants that greatly reduced PPIase activity. The mutants
are Y221G (C.P. Liu, G.C. Huang, Z.Y. Li and J.M. Zhou,
unpublished results) and F233Y [21]. In order to study the
relationship between the chaperone and PPIase activities in
vivo, we constructed an expression system to allow co-expres-
sion of adenylate kinase (AK) and TF in stoichiometric con-
centrations but induced by di¡erent promotors. The results
show clearly that co-expression with TF resulted in a higher
yield of soluble AK and more soluble AK was obtained when
the amount of TF produced was higher. Mutants, Y221G and
F233Y, show the same ability as wild-type TF in assisting
folding of AK but possess only 1% of wild-type PPIase activ-
ity. This provides in vivo evidence that the molecular chaper-
one activity of TF is distinct from its isomerase activity.
2. Materials and methods
2.1. Bacterial strain and plasmids
E. coli strain JM109 {endA1, recA1, gyrA96, thi, hsdR17 (rk3,
mk), relA1, supE44, v(lac-proAB), [FP, traD36, proAB,
laclqZvM15], pREP4} was used throughout this study. An expression
vector (pBVAK, derived from pBV220) for chicken AK mutant P17G
(Fig. 1A) was donated by Dr. X.-R. Sheng. Expression of AK was
induced by heat shock at 42‡C. Plasmid pQE60 contains the wild-type
tig gene that encodes TF and was donated by Professor G. Fischer.
TF mutants Y221G (C.P. Liu, G.C. Huang, Z.Y. Li and J.M. Zhou,
unpublished) and F233Y [21] were obtained via site-directed muta-
genesis of plasmid pQE60.
The vector for co-expression of AK and TF under control of di¡er-
ent promotors was constructed as follows: a pair of PCR primers was
designed to amplify the tig gene in pQE60 along with the T5 promo-
tor and SD sequence and to introduce a BamH1 restriction site at
both 5P and 3P ends. The resulting PCR product was inserted into
pBVAK at the BamH1 site, downstream of the AK gene. The desired
clones were selected and sequenced. This plasmid was named pBVAT
(Fig. 1B), and allows AK and TF to be induced separately. When
induced by heat shock at 42‡C, AK and TF are expressed together
from the same mRNA. Activation of the T5 promotor by addition of
isopropyl L-D-thiogalactoside (IPTG) results in expression of only TF.
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2.2. Media, chemicals, and culture conditions
2TY broth was used throughout. Tryptone and yeast extract were
from Oxoid, IPTG was from Promega and other chemicals were local
products of analytical purity.
Strains harboring the respective plasmids were cultured overnight at
30‡C. A 2 ml culture was added into 40 ml of media and grown with
shaking at 250 rpm at 30‡C until A600 nm reached about 0.6V0.8.
IPTG was then added to a ¢nal concentration of 0.1 mM for the
strain harboring pBVAT to induce TF expression (under the T5 pro-
motor) and the temperature was immediately increased to 42‡C for all
cultures to induce AK expression. After 4 h growth at 42‡C, cultures
were centrifuged at 8000 rpm at 4‡C for 10 min to collect the cell
pellets.
2.3. Sample processing
All the procedures of cell lyses and separation were performed at
4‡C. The pellets were washed with 0.9% NaCl then resuspended in 400
Wl lysis bu¡er (50 mM Tris, 150 mM NaCl, pH 8.0) plus 50 Wg
lysozyme and 100 WM phenylmethylsulfonyl £uoride (PMSF). The
cells were lysed by sonication for 2 min using a Cole-Parmer ultra-
sonic homogenizer CPX 600. Lysis products were centrifuged at
12 000 rpm for 10 min and the supernatant was set aside for analysis.
The pellets containing the inclusion bodies were washed with 2 M
urea, 0.1% Triton X-100, and 0.9% NaCl in turn with centrifugation
between each washing step and ¢nally dissolved in 400 Wl 6 M urea
and allowed to stand for 2 h. After centrifugation at 12 000 rpm for
10 min, the supernatants were collected for further analysis.
For each sample, 1 Wl of supernatant and 1 Wl of 6 M urea-solubi-
lized inclusion bodies were analyzed by 15% sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE) in duplicate. After
electrophoresis, one gel was subjected to Coomassie brilliant blue
staining and the other gel was used for the Western blot. The AK
bands on the nitrocellulose membrane were detected with anti-AK
McAb3D3 [16] and AP-conjugated goat anti-mouse IgG.
AK activities of supernatants or 6 M urea-solubilized inclusion
bodies were measured by the method following the reduction of
NADP in a coupled enzyme solution with hexokinase and glucose-
6-phosphate dehydrogenase in 50 mM Tris^HCl bu¡er (pH 8.1) [17].
10 Wl aliquots were taken from each reaction mixture for activity
measurements. The amount of AK was then calculated from the ac-
tivity (the speci¢c activity was 0.23 mmol mg31 min31).
PPIase activity of TF was assayed at 10‡C by the chymotrypsin-
Fig. 1. Plasmids for expression of AK (A) and for controlled co-expression of TF with AK (B). Abbreviations: ori, replication origin of
pMB1; Ampr, ampicillin resistant gene; PR/PL, promotor from V phage; Clts857, PR/PL repressor gene.
Fig. 2. Spectral properties of the two TF mutants. A: Trp £uorescence spectra of wild-type TF and the mutants. B: Far-UV CD spectra of
wild-type TF and the mutants.
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coupled method [18] using a tetrapeptide (succinyl-Ala-Ala-Pro-Phe-4-
nitroanilide, Peptide Institute Inc. Japan) as a substrate. An apparent
speci¢city constant 1.01 WM31 s31 [19] was used to calculate the
amount of TF. Thus the TF/AK ratio of each sample could be calcu-
lated.
Since the PPIase activity of the mutants, Y221G and F233Y, is too
low to be detected under the experimental conditions, the TF/AK
ratio of TF mutants was calculated by analyzing the images of Coo-
massie blue stained gels (dry gels scanned with a £atbed scanner)
using the gel analyzing software Totallab1 V1.01 (Nonlinear Dynam-
ics Ltd), using the average result of ¢ve gels.
Wild-type and the two TF mutants, Y221G and F233Y, were pu-
ri¢ed according to the method of Stoller [4] and were quanti¢ed as
described [20]. Fluorescence measurements were carried out on a Hi-
tachi F4500 £uorescence spectrophotometer. Fluorescence emission
spectra were recorded between 300 and 400 nm after excitation at
295 nm in a 1 cm cell. Both excitation and emission slits were set at
5 nm. Far-UV circular dichroism (CD) spectra were measured with a
Jasco J720 spectrophotometer in a 0.1 cm cell. The enzyme concen-
tration used was 0.2 mg/ml.
3. Results and discussion
3.1. Activity and conformation properties of TF mutants,
Y221G and F233Y
The mutants Y221G and F233Y used in the present study
show very low PPIase activity, so that the residual activities of
the mutants could only be measured with puri¢ed enzyme at
100 times higher amounts than the wild-type enzyme. The
substrate speci¢city of wild-type TF for the substrate succin-
yl-Ala-Ala-Pro-Phe-4-nitroanilide was 1540 mM31 s31 and
substrate speci¢city of F233Y was 15 mM31 s31, i.e. 1% of
that for wild-type TF. For the mutant Y221G, the measured
substrate speci¢city was 20 mM31 s31, about 1.3% of wild-
type. These results support the suggestions that residues Y221
and F233 of TF are involved in enzyme catalysis [21].
As shown previously, changes in the Trp £uorescence
mainly reveal conformational changes in the middle domain
of TF while changes in the far-UV CD spectra principally
re£ect the changes in the structure of terminal domains of
TF [19]. The Trp £uorescence of the two mutants showed a
red shift compared with wild-type TF (Fig. 2A). This indicates
loosening of the structure of the middle domain. The CD
spectra of the mutants show no signi¢cant di¡erence to
wild-type TF (Fig. 2B), indicating that the structures of the
two terminal domains (N and C) were not a¡ected by the
mutations. The isomerase activity of TF is dependent on the
middle domain and the observed minor conformational
change may account for the loss in isomerase activity.
3.2. Controlled expression of TF and AK
In the present study, the plasmid pBVAK was used to ex-
press AK alone and pBVAT was constructed to express AK
and TF together under the control of separate promotors.
When AK was induced by heat shock at 42‡C of the strain
harboring pBVAK, 95% of the expressed AK was found in
inclusion bodies. The proteins expressed from pBVAK or
pBVAT under heat shock alone were nominated as samples
‘AK’ or ‘AThs’. The proteins expressed by pBVAT induced
using heat shock and 0.1 mM IPTG were nominated as sam-
ple ‘AThsIPTG’. For the strain harboring pBVAT, TF and
AK genes were proceeded by T5 and PR/PL promotors respec-
Fig. 3. The relative expression levels of total TF (wild-type) to AK
under di¡erent conditions. Samples ‘AThsIPTG’, ‘AThs’ and ‘AK’
represent proteins expressed by plasmids pBVAT induced by heat
shock and IPTG, plasmid pBVAT induced by heat shock only and
plasmid pBVAK induced by heat shock, respectively. The ratios
were measured by activity assay as described in Section 2.
Fig. 4. The co-expressed wild-type TF and AK in supernatants and
inclusion body fractions. A: Proteins analyzed by SDS^PAGE (15%
polyacrylamide gel) stained by Coomassie blue R250. B: The bands
of AK detected by Western blot. Columns 1, 3, 5: supernatants (S)
of samples ‘AThs’, ‘AThsIPTG’ and ‘AK’, respectively. Columns 2,
4, 6: insoluble (I) components of samples ‘AThs’, ‘AThsIPTG’ and
‘AK’, respectively. Samples were treated as described in Section 2.
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tively, so TF was under the control of both the T5 and the PR/
PL promotors while AK was under the control of only the PR/
PL promotor. When cultured at 30‡C without IPTG, there
was no recombinant TF expressed. Thus, under the experi-
mental conditions, strains harboring pBVAK or pBVAT
under heat shock or both heat shock and IPTG could express
AK only, AK and certain amount of TF, or AK and large
amount of TF, respectively. The expression levels of wild-type
TF and AK in di¡erent strains were presented as a ratio of
total TF/AK and are compared in Fig. 3. The total amount of
TF expressed in pBVAT induced by heat shock and IPTG
was 2.8 times the amount of AK. In pBVAT induced by
only heat shock the amounts of TF and AK were approxi-
mately equal.
3.3. Co-expression of TF with AK increases the yield of soluble
AK
The e¡ects of co-expressed TF on the solubility of AK were
further analyzed and the results are shown in Fig. 4A and B.
The SDS^PAGE and the western blot of the supernatant and
inclusion bodies for the proteins expressed by pBVAK and
pBVAT strains under di¡erent culture conditions show dra-
matic di¡erences. In sample ‘AK’, about 95% of the recombi-
nant AK was found in the insoluble fraction (lanes 5, 6 in Fig.
Table 1
The relationship between soluble AK and the amount of co-expressed TF
Expression conditions Soluble AK TF/AK
pBVAK heat shock 6 5% 0
pBVAT heat shock (sample ‘AThs’) 25 þ 4% 1.1 þ 0.2
heat shock, 0.1 mM IPTG (sample ‘AThsIPTG’) 65 þ 7% 2.8 þ 0.3
pBVATY221G heat shock (sample ‘ATY221G;hs’) 15 þ 3% 1.2 þ 0.4a
heat shock, 0.1 mM IPTG (sample ‘ATY221G;hsIPTG’) 52 þ 7% 2.9 þ 0.5a
pBVATF233Y heat shock (sample ‘ATF233Y;hs’) 20 þ 3% 1.1 þ 0.3a
heat shock, 0.1 mM IPTG (sample ‘ATF233Y;hsIPTG’) 60 þ 8% 2.7 þ 0.5a
aThe TF/AK ratio for TF mutants was calculated by analyzing images of Coomassie blue stained gels using Totallab1 V1.01 (Nonlinear Dy-
namics Ltd), using the average result of ¢ve gels.
Fig. 5. The co-expressed TF mutants and AK in supernatants and inclusion body fractions. A: Proteins analyzed by SDS^PAGE (15% polyac-
rylamide gel) stained by Coomassie blue R250. B: The bands of AK detected by Western blot. Columns 1, 3, 5, 7: supernatants (S) of samples
‘ATY221G;hs’, ‘ATY221G;hsIPTG’, ‘ATF233Y;hs’, ‘ATF233Y;hsIPTG’, respectively. Columns 2, 4, 6, 8: insoluble (I) components of samples ‘ATY221G;hs’,
‘ATY221G;hsIPTG’, ‘ATF233Y;hs’, ‘ATF233Y;hsIPTG’, respectively. Samples were treated as described in Section 2.
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4A and B). When TF was introduced into the expression
system (samples ‘AThs’ and ‘AThsIPTG’), the total amount
of recombinant AK decreased to a certain degree. However,
the amount of soluble AK increased signi¢cantly (lanes 1^4 in
Fig. 4A and B). The quantities of TF and AK in each sample
were determined by measuring enzyme activities of AK and
TF in both supernatant and refolded inclusion body fractions.
As shown in Table 1, soluble AK accounted for more than
60% of the total synthesized AK in sample ‘AThsIPTG’, in
which the molar ratio of expressed TF to AK was about
2.8:1 (Fig. 2). There was 25% soluble AK in sample ‘AThs’,
in which the molar ratio of expressed TF to AK was about
1:1. For sample ‘AK’, in which no TF was expressed, soluble
AK was only 5%. This shows clearly that co-expression of TF
with AK increases the amount of soluble AK and it is clearly
related to the quantity of co-expressed TF.
When TF mutants Y221G or F233Y were co-expressed
with AK, the amount of soluble AK also increased with in-
creasing levels of mutant TF co-expression (Fig. 5). In this
case the amount of mutant TF was quanti¢ed by SDS^PAGE
since the mutants had no detectable activity in the co-ex-
pressed systems. The soluble AK was determined using the
activity assay as before. As shown in Table 1, the results
are essentially the same as for wild-type TF. This provides
direct evidence that in vivo chaperone activity of TF is distinct
from its PPIase activity.
From the current study we cannot rule out the possibility
that a low level of PPIase activity is required for AK folding
in addition to the chaperone activity. However, even if this is
the case, it is clear that the PPIase activity alone is not su⁄-
cient for AK folding. Further, it is the chaperone activity that
is limiting for AK folding and at least stoichiometric binding
is required. The level of chaperone activity in the mutant TF
proteins is essentially undiminished and is clearly distinct from
the PPIase activity.
It has been suggested that TF assists GAPDH refolding in
vitro by repeated binding^releasing cycles [16]. A number of
TF molecules may bind to a single substrate molecule where
there are two or more hydrophobic binding sites available on
the target protein. The higher the concentration of TF, the
larger the number of binding^release cycles and the higher the
degree of protection of target proteins from aggregation.
Hence more folding intermediates have the chance to reach
the native state. The results presented here show that di¡erent
levels of TF co-expression resulted in di¡erent chaperone e⁄-
ciency in E. coli. When the TF level was low (as in the sample
‘AThs’), AK is still prone to aggregation. This suggests either
that each nascent AK molecule needs help from more than
one TF molecule or that the binding a⁄nity requires higher
levels of TF to achieve e¡ective binding. The similarity be-
tween these and in vitro results [16] suggests that TF assisted
folding in the two systems may occur by a similar mechanism.
Early in folding of the nascent polypeptide, interaction of
exposed hydrophobic surfaces may be the main route to ag-
gregation. High concentrations of TF may block this interac-
tion and decrease the rate of aggregation, thus allowing more
nascent polypeptides to follow the pathway to correct folding.
Maturation of nascent AK requires a certain microenviron-
ment. It is important that nascent polypeptides be insulated
from each other. For recombinant proteins, large quantities of
nascent polypeptides are synthesized simultaneously. This
crowding then results in aggregation. When a su⁄cient num-
ber of TF molecules are available in the surrounding environ-
ment, these TF molecules can bind to nascent polypeptides so
as to form a relatively closed microenvironment and prevent
interaction between nascent polypeptides. Thus, the produc-
tivity of nascent polypeptide folding can be improved. This
indicates the potential of TF to improve the yield of recombi-
nant heterologous proteins for medicinal and other biotech-
nological purposes.
Earlier studies have shown hints that TF binds to nascent
polypeptides and cooperates with chaperones such as GroEL
and DnaK [7^12,15]. Here we provide experimental evidence
that TF is e¡ective as a molecular chaperone in the folding of
a heterologous protein in vivo.
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